VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO Breast 2022 | Gene expression assays to identify patients with breast cancer for neoadjuvant treatment

Gaia Griguolo, MD, University of Padova, Padova, Italy, talks on utilizing gene expression assays to aid in identifying subgroups of patients with HR-positive/HER2-negative breast cancer who have superior response rates to particular agents. Such assays could help to identify candidates for treatment in the neoadjuvant setting. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter